Sensus Blog

The future of skin cancer treatment is now. Stay ahead of the curve with our library of informational blogs.

April
27
2026

Basal Cell Carcinoma vs. Squamous Cell Carcinoma: What’s the Difference?

Melanoma and non-melanoma are two primary categories of skin cancer. Each presents different symptoms and treatment options. Within the non-melanoma skin cancer – sometimes referred to as NMSC – category, the two most common types…

September
07
2018

Sensus Healthcare Presents at National Cancer Care Alliance Leadership Board and Practice Quarterly Meeting

BOCA RATON, Fla., Sept. 7, 2018 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), today announced that…

August
27
2018

Sensus Healthcare to Participate in Two Upcoming Investor Conferences

BOCA RATON, Fla., Aug. 27, 2018 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), today announced that…

August
24
2018

What You Should Know About Your Family’s History of Skin Cancer

Do you know your family’s history of skin cancer? If one or more of your parents, siblings, or children develop skin cancer, you have a higher risk of developing skin cancer than a person with…

August
24
2018

Making Sense of the Link Between Skin Color and Skin Cancer

While those with lighter skin tones are generally the most at risk for skin cancer, anyone with any skin color can get skin cancer. Unfortunately, many patients are under the impression that those with darker…

Archives
Archives

IN THE NEWS

CEO Joseph Sardano on Coding for Superficial Radiation Therapy